Electrochemical biosensors are redefining cancer diagnostics, providing rapid, highly sensitive detection of circulating and tissue-specific biomarkers. Beyond simple detection, they reveal molecular interactions that drive tumor progression and therapeutic response. Integration with nanomaterials and signal amplification improves detection at very low biomarker concentrations. For oncologists, this technology offers early insights into tumor heterogeneity, minimal residual disease, and emerging resistance.
Understanding these nuances enables more precise, personalized treatment planning and monitoring. Take the quiz today and see how well you’re keeping pace with the future of oncology diagnostics. ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we make no explicit or implied warranties about the…
